Taken together, TMEM106A serves as an independent prognostic factor and is associated with more aggressive glioma behavior, underscoring its potential prognostic utility, particularly in IDH‐wildtype astrocytomas (IDHwt). Here, IDH1 is linked to central nervous system cancer.